R E Johnson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cyclophosphamide/therapeutic useFemaleHumansLeukemia, Lymphoid/drug therapyLeukemia, Lymphoid/mortalityLeukemia, Lymphoid/radiotherapyMaleMiddle AgedPrednisone/therapeutic useRadiotherapy DosageRemission, Spontaneous
Substances: See more » CyclophosphamidePrednisone
Year: 1979 PMID: 457467 DOI: 10.1016/0360-3016(79)90714-4
Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN: 0360-3016 Impact factor: 7.038